NUS NU SKIN ENTERPRISES, INC.
Data as of close
Industrials · Wholesale-Drugs, Proprietaries & Druggists' Sundries
NU SKIN ENTERPRISES, INC. (NUS) is an industrial company in the Wholesale-Drugs, Proprietaries & Druggists' Sundries industry, with a market capitalization of $233 million. Shares last traded at $4.78, 59.0% below their 52-week high. Over the past year the stock is down 55.0%. Net profit margin is -15.7%, below the peer median of 0.7%. Revenue declined 14.3% year over year. The shares yield 29.0% in dividends.
* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.
Performance
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
Financials
Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-06-30. Source: SEC EDGAR/XBRL.
NUS Dividend History
| Fiscal year end | Total dividends paid | Per share* | Payout ratio |
|---|---|---|---|
| 2025-12-31 | $12M | $0.24 | 7% |
| 2024-12-31 | $12M | $0.24 | — |
| 2023-12-31 | $78M | $1.56 | 903% |
| 2022-12-31 | $77M | $1.52 | 74% |
| 2021-12-31 | $76M | $1.48 | 52% |
| 2020-12-31 | $78M | $1.49 | 41% |
| 2019-12-31 | $82M | $1.47 | 47% |
| 2018-12-31 | $81M | $1.43 | 66% |
| 2017-12-31 | $76M | $1.39 | 59% |
| 2016-12-31 | $78M | $1.40 | 55% |
| 2015-12-31 | $81M | $1.37 | 61% |
| 2014-12-31 | $81M | $1.34 | 43% |
*Per share derived as total dividends paid ÷ weighted diluted shares (SEC EDGAR/XBRL annual cash-flow facts). Reported history — not a forecast of future dividends.
Compare payers on the highest-dividend-yield screener.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q2 2026 | -$5.14 | 2026-08-10 |
| Q1 2026 | $0.04 | 2026-05-08 |
| Q4 2025 (derived) | $0.27 | 2026-02-13 |
| FY 2025 | $3.18 | 2026-02-13 |
| Q3 2025 | $0.34 | 2025-11-07 |
| Q2 2025 | $0.43 | 2025-08-08 |
Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.
Wholesale-Drugs, Proprietaries & Druggists' Sundries peers
NUS vs 9 industry peers (Wholesale-Drugs, Proprietaries & Druggists' Sundries), by market cap. Data as of close
| MCK | McKesson Corporation | $116.4B | 25.36 | 0.28 | 1.1% | +0.30% |
| COR | Cencora | $64.5B | 24.57 | 0.19 | 0.8% | +2.11% |
| CAH | Cardinal Health | $59.2B | 35.59 | 0.24 | 0.7% | +1.53% |
| HLF | Herbalife Ltd. | $1.4B | 7.75 | 0.26 | 3.4% | +1.68% |
| NUS | NU SKIN ENTERPRISES, INC. | $233M | — | 0.17 | -15.7% | +2.36% |
| COSM | Cosmos Health Inc. | $31M | — | 0.42 | -33.1% | -0.70% |
| ESYN | HWH International Inc. | $13M | — | — | — | -6.42% |
| MEDS | DataMeds AI, Inc. | $5M | — | — | — | -8.25% |
| HKPD | Cellyan Biotechnology Co., Ltd | $2M | — | — | — | -12.74% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.